Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Biomaterials. 2015 Feb 19;51:208–215. doi: 10.1016/j.biomaterials.2015.02.015

Figure 5.

Figure 5

Efficacy of NP HDACIs as radiosensitizers in chemoradiotherapy for solid tumor cell lines in vivo. Mice bearing flank tumor xenografts were administered (intravenous) with saline, vorinostat, NP vorinostat, quisinostat or NP quisinostat followed by radiotherapy. Tumors were irradiated to a total dose of 3 Gy at 3 h after chemotherapy injection. Changes in tumor volume were measured and the tumor growth delay curves for mice bearing PC3 (A) and SW620 (B) tumors were generated.